The GDP offers one-to-one mentoring, alongside professional and clinical skills development in primary care practices across the UK.
Chloe Roberts, clinical and educational development manager at Linnaeus, said: “This fourth cohort of graduates is looking likely to be the biggest yet, which is testament to how successful the programme has become over recent years.
“We’ve received so many high-quality applications and look forward to welcoming many of them into our practices.
“There’s still time left for people to apply via our online portal, so we’d love to hear from any prospective candidates interested in roles in the Midlands and Yorkshire.”
Linnaeus delivers all clinical training in-house through its extensive network of specialists, referral clinicians, certificate holders and experienced primary care clinicians.
Graduates take part in 20 core educational days as part of their clinical and professional skills training, with access to an additional 10 CPD days to undertake training of their own choice over the course of the programme.
For more information about the Graduate Development Programme, visit https://graduates.linnaeusgroup.co.uk.
Photo: Bristol University graduate Abigail McCarthy, a vet at Blacks Vets in Dudley
The ESVE has become aware through its Endocrine Quality Assurance (EQA) Scheme that there will be a permanent change in the antibody used for the cortisol test for the Siemens Immulite 2000.
The change affects the antibody pool from kit Lot 550 onwards, meaning that it has already affected some laboratories and others will be affected in the next few weeks to months. At present, the new antibody lots are not being released to the USA market. Other analysers are unaffected.
The ESVE has been working with the laboratories in its EQA scheme to quantify the impact on results and reference limits. The Society says an initial review by the ESVE-EQA based on >400 canine serum and >40 urine results suggests that canine serum cortisol results are lower (average bias -23% in canine serum) than diagnostic laboratories and clinicians have been used to in the past. The effect is more marked in canine urine cortisol (average bias -70%).
Since being alerted by the ESVE-EQA, the manufacturer has derived mathematical adjustment factors that laboratories can incorporate into their systems to mitigate the impact on results. If the manufacturer adjustment is used, then the results will be around 8% lower on average in serum and around 60% lower in urine. Cut-offs to diagnose hyperadrenocorticism and rule out hypoadrenocorticism may need to be validated again with the new assay. There is not yet sufficient data in the ESVE-EQA collaboration to assess the impact on feline and equine samples.
Professor Ian Ramsey, President of the BSAVA and one of the founders of ESVE, said: “Individual laboratories may have different ways of dealing with this change and therefore it is important to keep in touch with your laboratory provider concerning their approach. Some may choose to make the mathematical adjustments to results so that common and historic cut-off values can continue to be used. Others may report their results directly but change their guidance on interpretative cut-off values."
Dr Peter Graham, ESVE-EQA Co-ordinator, concluded: “ESVE advises that all cortisol results from Siemens Immulite 2000 assays that are close to a threshold are interpreted cautiously. ESVE also advises that all endocrine results should be interpreted in the light of clinical findings and would like to remind clinicians that spurious results may occur in any assay, though this is rare.”
The BSAVA and ESVE encourage laboratories to tell clinicians which analyser they are using. Suitable wording regarding the interpretation of any values of cortisol based on Siemens Immulite 2000 results should be provided by laboratories for the foreseeable future.
Photo: A dog with hyperadrenocortism, courtesy Professor Ian Ramsey
The campaign was officially launched at an event at the Palace of Westminster sponsored by Kevan Jones MP (Labour, North Durham) who has spoken about his own experiences with depression, and featured first-hand testimonials from senior veterinary surgeons and doctors who have experienced mental ill-health.
‘&me’ is a collaboration between the RCVS Mind Matters Initiative, which seeks to address mental health and wellbeing issues within the veterinary profession, and the Doctors’ Support Network, which provides peer support for doctors and medical students with mental health concerns.
Introducing the campaign, Mr Jones said: "The key message I have today in regards to mental health is talking about it and trying to get it out of the dark corners rather than it being something you are ashamed to talk about. That is how we get people to help themselves with their own condition and to seek help. The other key thing is not to write people off if they have a mental illness."
The floor was then opened to personal stories from those who have lived experience of mental ill-health. Dr Louise Freeman is Vice-Chair of the Doctors’ Support Network and was diagnosed with depression in 2009 as a result of the way in which her return to work was handled after having time off work as an emergency medicine consultant following a bereavement.
She said: "This experience made me think that doctors with mental health problems were in a small minority and that it was probably our own fault anyway. Both impressions are completely wrong. The incidence of mental health problems is one in four people in any one year and is actually higher for doctors, who are often slower to seek help than non-medics. The good news is that well supported doctors have excellent treatment outcomes.
"During my own return to work, I was told by my clinical lead that they had 'always thought that I was a mental health problem waiting to happen.' I think this says more about them than it did about me! On reflection, yes that was true, but only inasmuch as this applies to all of us during our lives.
"I hope that the ‘&me’ campaign can start to address this by encouraging senior healthcare professionals, who are currently well, but have experienced mental health problems, to disclose that they have 'been there themselves'. I think that this will help to normalise mental ill health for healthcare professionals and therefore remove some of the barriers to unwell professionals seeking help at an earlier stage. Overall this would be better for healthcare professionals, their colleagues and their patients."
David Bartram, Director of Outcomes Research for the international operations of the largest global animal health company and a member of the Royal College of Veterinary Surgeons' governing Council, spoke next. He gave his perspective on coming to terms with a mental health condition in a profession that has some stigma attached to it.
A number of years ago David attempted suicide following the breakup of his marriage and explains what happened from there: "I just thought I was stressed – after all, who wouldn’t be in those circumstances? But in fact I was becoming progressively more unwell. What started as worry, early waking and palpitations – which I recognised – led to patterns of thinking which I did not recognise as being disordered. I felt trapped and worthless – suicide was the only escape. From a medical perspective, my biological, social and psychological risk factors had converged and tipped me into major depression.
"That was the first of multiple suicide attempts and several prolonged stays in hospital. Over a three-year period I spent 12 months as a psychiatric inpatient. I was treated with antidepressants, antipsychotics, mood stabilisers, talking therapies and electroconvulsive therapy.
"But now thankfully I am well – and I have been for 14 years…. To what do I attribute my recovery? A mixture of medical treatment, psychological therapies, supportive friends and family, rest and time – they all contributed, probably in similar measure."
He added that while his episode of mental ill-health does not define him it has changed him in a positive way and that no one is immune from it.
Dr Jonathan Richardson is Group Medical Director for Community Services at the Northumberland, Tyne and Wear NHS Foundation Trust who had a mental health condition when he was a medical student and spoke about how it is possible to flourish in your career with a mental health diagnosis.
"I was unwell as a teenager with a physical illness and later as a medical student with a mental illness… these two experiences crystallised my drive to become a doctor and my own approach to healthcare. I wanted to be able to deliver the care that I was fortunate to receive. I wanted to be as patient-centred and compassionate with the patients I would serve, in the same way as the teams who delivered my care. I was lucky to have support when I was unwell from very good friends, some from school and some from university; and a very close family. I have been able to recover.
"It is 24 years since my mental illness. I now work in Northumberland, Tyne and Wear NHS Foundation Trust, one of the largest mental and learning disability health trusts in England – and one of only two to be rated outstanding by the Care Quality Commission…. I do not feel that my illnesses have stopped me."
Dr Angelika Luehrs is the chair of the Doctors’ Support Network and a consultant psychiatrist who was diagnosed with bipolar affective disorder while she was a trainee psychiatrist. She said: “When I asked for advice about how to access help one of the answer I got was one of ‘whatever you do, make sure that you don't have any mental illness in your medical records otherwise you will never go anywhere in your medical career. However, getting the diagnosis and help from a Consultant Psychiatrist was the best thing that ever happened.”
She added: "The reality is that my diagnosis has not stopped me – I have been a consultant psychiatrist since 2010 with the Avon and Wiltshire Mental Health Partnership NHS Trust, last year I was appointed as medical lead for West Wiltshire including early intervention, intensive services and primary care liaison services. I have a special interest in supporting doctors with mental illness and I am delighted to be appointed by the newly launched GP Health Service as a special advisor for complex mental health cases."
The last speaker was veterinary surgeon Neil Smith who chairs the RCVS Mind Matters Initiative and outlined how to participate in the campaign. He said: "This event is just the start… the real challenge is to start to get this message out to the wider professions. Stigma is a difficult thing to tackle, but the good news is that changing our minds is within the power of every individual to do."
Following the launch the ‘&me’ campaign is now encouraging other senior health professionals to step forward and talk about their own experiences with mental ill-health, especially as both medical doctors and veterinary surgeons have higher suicide rates than the general population but often have more reluctance to seek help because of the impact it may have on their career.
The campaign is interested in hearing from not only doctors and veterinary surgeons but also nurses, veterinary nurses, dentists, pharmacists and other healthcare professionals who want to open up about their experiences of mental ill-health. To participate in the campaign email Dr Louise Freeman on vicechair@dsn.org.uk.
Further information about the ‘&me’ campaign can be found at www.vetmindmatters.org/&me
Moral Maze, a debate held by members at the British Equine Veterinary Association (BEVA) Congress earlier this month, has concluded that equine practice needs to adapt to accommodate family life.
92% of voters agreed with the motion: Equine practice needs to change to become more compatible with family life.
BEVA says the result may reflect in part the changing demographics of the profession, with females now accounting for 76% of new graduate intakes.
Traditionally vets have worked together in practices, able to share resources and expertise as well as the out-of-hours rota. Until recently, men from the Baby Boomer Generation dominated the profession and many vets focused their efforts on work at the expense of their family. However, as Generation Y takes hold and more females are joining equine practice, there are different personal expectations with many vets now wanting greater commitment to family life and a better work-life balance.
The session took the form of a moral maze debate, chaired by Malcolm Morley, in which expert witnesses were challenged by informed interrogators. The proposers contended that it is possible to achieve a good work-life balance as an effective vet in a successful equine practice by working smarter, not harder and adopting a flexible approach.
Carolyne Crowe, veterinary coach and mentor, said: “Choosing to be an equine vet shouldn’t go hand in hand with giving up the rest of your life. Allowing flexibility within job roles should result in more engagement, productivity and thus economic benefit for the practice.”
Job share that included a proportionate allocation of the out-of-hours rota, was cited as a tenable solution for those juggling maternity leave and parenthood. The consistency of attending vets so often demanded by clients could be achieved by introducing two vets of equal calibre to the client, from the outset. Members of the audience outlined successful examples of job sharing and the consensus was that the turnover generated by part time, job share employees was often higher than their full time equivalents.
Mark Bowen, President of BEVA, said: “I’m not surprised that 92% of voters supported the motion, given the fact that the recent Vet Futures survey has shown a high rate of job dissatisfaction in equine practice. It reiterates the importance of moving with the times to evaluate the needs of working parents and make the equine veterinary workplace more adaptable to family life.”
BEVA is already working on various projects to help address and support the needs of members who are striving for a better work-life balance. CPD on personal effectiveness, covering work-life balance and time management is scheduled for the New Year. Further information on other initiatives will be released towards the end of the year.
The debate can be viewed online for free at beva.org.uk in the webinar tab.
MDC Exports has launched the Soft E Collar in a small size suitable for rabbits.
According to the company, the Soft E Collar provides an effective barrier to a treatment area while ensuring an animal can eat, drink and sleep in comfort. It allows free movement of the head, neck and body so an animal can carry on as normal, being less likely to get depressed during recovery.
MDC says that unlike a traditional 'Elizabethan' collar, the Soft E Collar is flexible, lightweight, can withstand chewing, folds flat for easy storage and springs back into shape when needed.
Sandra & Steve Ayers, RSPCA Rabbit Rehoming, Reading Branch said: "We fitted the collar for a few days on a newly spayed rabbit. It didn't appear to get in the way when she was feeding and looked less cumbersome than the traditional plastic buster collars."
Melvyn Driver, Managing Director of MDC Exports said: "The design of our Soft E Collars has proved to provide great relief for dogs and cats post op, giving them a better quality of life at a difficult time. We're delighted that vets and rabbit welfare officers are championing the Soft E Collar too, as rabbits deserve the best care too."
For more information about the Soft E Collar, visit www.mdcexports.co.uk.
The programme is for vets who are more than five years qualified, and thus not eligible for BEVA’s Leg Up coaching.
It has been developed in response to numerous BEVA members reporting periods of feeling lost or adrift in their career as life progresses after graduation, particularly following a career break.
The programme is led by a team of individuals who have experienced the challenges of working in equine practice and have all undergone extensive coaching training.
It takes the form of group sessions where participants can discuss, learn and share knowledge in a workshop style environment.
Lucy Grieve, Veterinary Projects Officer at BEVA said: “Back in the Saddle provides a safe, supportive and encouraging environment to help individuals understand what it is they want from their career, following a break, for example for parental leave or injury.
"By reflecting on their career achievements, learnt skills and professional needs, in the context of their life as it is now, it enables them to prioritise appropriately, create achievable goals, and find their place in the profession again.
“Our coaches are professionally trained, friendly and empathetic, and the nature of group coaching means peer support opens up to all involved.
"This helps counter feelings of isolation and self-doubt and enables a sense of purpose and confidence to return and develop further.”
The first Back in the Saddle programme starts on 11 June 2024 – applications are now open and will close on 17 May 2024.
https://form.asana.com/?k=5BoRR89NDXQ_CAsWZ-g-HQ&d=11947487954206
For the study “Comparative accuracy of two veterinary-calibrated point-of-care glucometres for measurement of blood glucose concentration in dogs” blood was sampled from client and staff-owned dogs above 6 months of age, of various breeds and health status.
The samples were then used to compare the accuracy of both PGBMs against a reference method - the hexokinase reaction method.
The authors say this was the first study to investigate AccuTell and the first published evidence comparing AlphaTrak2 with a reference method.
The study also sought to determine how useful the monitors are in clinical decision making and to assess the effect that packed cell volume (PCV) (known to affect the reliability of blood glucose concentration measurement in dogs) has on blood glucose concentration using the two PBGMs.
AccuTell was found to be more accurate and useful in a clinical setting than AlphaTrak2.
Both PBGMs were inaccurate in comparison with the hexokinase reaction method, and although they have potential for standard clinical use, unexpected blood glucose concentrations need to be checked by the hexokinase reaction method.
In addition, measurement of blood glucose concentration by the AlphaTrak2 was affected by PCV whereas measurement by the AccuTell was not.
Nicola Di Girolamo, Editor of JSAP said: “We oftentimes think that an instrument that is developed specifically for our patients will provide satisfactorily results on most occasions.
"Instead, studies such as the one presented here, are critical to understand whether the ‘numbers’ provided by an instrument are reliable for clinical use.
"The authors provided 95% limits of agreements to their results.
"This value is of great help for clinicians, since it shows the difference expected between the instrument and the reference standard in the majority of occasions.”
The study can be read online here: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jsap.13491
Reference
Hosted by Nick Steele, National Consulting Manager at Zoetis and Rachael Whittle, a business coach specialist, the course will present the best techniques to analyse mixed personalities that cause problematic situations, allowing staff to deal with difficulties that may occur on a daily basis. Nick will use his knowledge from working at the world’s largest global animal health company, while Rachael will use her experience in business training and coaching to help anyone that works with people on a daily basis manage these daily challenges, using common examples from their own background.
For the chance to win a free place at this event, send an email with your name, the name of your veterinary practice and the reason attending this course will help grow your practice’s business to royalcaninvet.gbr@royalcanin.com.
Royal Canin will select three applicants at random, and will inform the winners via email, by Thursday 30 June.
Places on the course can also be booked by calling 01453 872731 or by visiting www.spvs-vpma-events.co.uk. Workshops cost £265 plus VAT for non-members and £190 plus VAT for VPMA and SPVS members (group/ bulk booking discounts are also available). Cost includes CPD certificates, lunch and refreshments.
All donations of unwanted clothes, books or bric-a-brac are sent for sale in one of the charity's 55 charity shops around the UK.
Working in partnership with National Veterinary Services (NVS), empty donation bags are given to veterinary practices to fill with goods for NVS to collect and deliver to the charity. The partnership with NVS began in 2011 and so far over 60,000 bags have been collected, with an estimated value of over £1m.
Mark Corbett, Head of Retail at Blue Cross said: "We are extremely grateful to NVS, the vet practices taking part in the scheme and their clients. Although the donated items may be unwanted possessions to some, each bag generates about £20 of income for us. This means the scheme has so far provided an incredible amount of income towards helping the pets in our care.
Blue Cross receives no government funding, so relies on public donations to continue its vital work.
Veterinary practices that receive their stock and drugs from NVS but are not yet part of The Blue Cross donation scheme can sign up now by contacting their NVS representative or email trading@bluecross.org.uk.
Vetoquinol has launched www.epiphenonline.co.uk, to support the veterinary profession and dog owners in the management of epilepsy.
The company says it has developed the online service to complement its existing monitoring aids and booklets, and give the best possible support to vets and patients during the complex process of stabilising and managing seizures.
The online service enables owners to keep a seizure diary, and share it with their veterinary surgeon so that they can prescribe an appropriate medication and management programme.
According to Vetoquinol, approximately three to five per cent of dogs suffer from idiopathic epilepsy, (which accounts for 80 per cent of epileptic seizures). The condition is inherited in some breeds, including Beagles, Dachunds, Keeshonden, German Shepherds and Belgian Tervurens.
Documenting the animal's history and seizure activity is crucial in assessing the progression of epilepsy. It also provides invaluable information for diagnosis and maintenance of effective therapeutic control.
A survey commissioned by a new Sky TV series, Pets for Life, carried out in association with The Blue Cross, has found that 500,000 (2%) of Britain's 24 million pet owners say they no longer have money for their pet's food and are reduced to feeding the household animal with leftovers.
The survey also found that while two-thirds of pet owners dig deep into their pockets to find an average of £11.04 each week to care for their pets, one in five (21%) say they are dropping essentials such as visits to the vet in a bid to bring the weekly pet bill to under £5.
The poll of 1,200 pet owners indicated that higher insurance premiums, rising vet bills and rocketing pet-food prices have pushed the cost of owning a pet up to £574.08 a year. Nearly half of pet owners (47% or 12.2 million people) now spend an average of £9.40 on their pet each week, with a further 15% (3.9 million people) spending £19.50 a week, and 7% (1.8 million people) forking out more than £60 a week to keep their animals healthy and happy.
This comes as The Blue Cross revealed a 19% increase in stray and abandoned animals taken into its adoption centres in the last year compared to the same period the year before, with a total of 38 rabbits, 979 cats, and 419 dogs left to wander the streets. In addition, over 4,000 animals were given up voluntarily, many for financial reasons such as the owner being made homeless, having to move house or losing their job.
Laura Sleight, head of media relations at The Blue Cross said: "We pride ourselves on being a nation of animal lovers, but the sad reality is that some pet owners can either no longer afford to keep their pets or are unable to provide a suitable home for them. Animals add so much to our lives but it's important that people understand the cost, time and commitment involved before taking one on. Pets for Life aims to tackle these issues and provide real solutions to the everyday problems that can result in animals being given up or abandoned."
Pets for Life is on Sky Showcase (Channel 201, Freesat 403) on Sunday 8th May at 6:00pm and on Tuesdays at 7:30pm (repeated on Sundays) for at least a further seven weeks thereafter.
A DNA test which will save foals from unnecessary pain and suffering, and ultimately death, has been launched by the Animal Health Trust.
Foal Immunodeficiency Syndrome (FIS), a genetic disorder which is known to affect Fell and Dales ponies, causes foals to become anaemic and prone to opportunistic infections. Any foal born with the syndrome will not survive.
The new diagnostic DNA test, which costs £40, is the result of ten years of research by the Animal Health Trust (AHT) and the University of Liverpool. The test will not only identify foals which have the fatal condition but will highlight adult ponies who are carriers of the genetic trait which causes the syndrome. Affected foals will be prevented by avoiding covering a carrier mare with a carrier stallion.
Owners and breeders who wish to find out the genetic status of their ponies can arrange for a simple pulled mane or tail hair sample to be taken by a vet and submitted to the AHT. The Fell Pony or Dales Pony Societies will supply sample bags for submission on request. A fast-track system to identify foals suffering with the condition will report results within three working days.
The team that developed the DNA test was led by the AHT's Dr June Swinburne and Professor Stuart Carter of the University of Liverpool with research student Laura Fox-Clipsham. They believe that by using the test, owners and breeders will eventually be able to eradicate this awful condition.
Dr. June Swinburne, said: "The DNA test gives owners and breeders the power to overcome this devastating illness. It enables them to make informed decisions about which ponies to breed. We have already had samples submitted by HM The Queen from her own breeding stock of Fell ponies. I'd urge any breeders of Fell or Dales ponies to submit samples in order to arm themselves with the facts they need to prevent the birth of affected foals and thereby avoid this distressing condition."
Professor Carter, said: "The research, and ultimately the DNA test, has only been possible thanks to funding from The Horse Trust and the support of the Fell Pony Society and the Dales Pony Society who have supplied DNA samples. We consider that the efforts of all involved in enabling this research have lead to a major advance in animal welfare."
For more information on testing, contact the Fell or Dales Pony Societies. Alternatively visit the AHT website http://www.aht.org.uk/genetics_fis.html or email FIStesting@aht.org.uk
Bayer Animal Health has launched Back to Basics, a new guide to antibiotic use which focuses on the concerns raised by vets and vet students about antibiotics in a survey carried out by the company.
465 vets and 40 students took part in the survey in March 2014. Of these:
27% of vets admitted that they struggle to know which antibiotic is the most appropriate for a specific condition. This uncertainty was particularly the case if the patient is un-responsive to the vet's first choice antibiotic, or the condition develops to require a new or additional antibiotic choice. Bayer says it is also clear that many vets may not be aware that pradofloxacin is the least likely of the veterinary fluoroquinolones to select for antibiotic resistance,2 as 23% of vet students and 9% of vets said they believe that all antibiotics carry the same risk of selecting for resistance.
The company says Back to Basics is designed to fill the gaps in knowledge identified by the survey. It presents each of the major classes of veterinary antibiotic and details how they work. It also includes an antibiotics 'jargon buster' to help vets and vet students better understand the commonly used measures of antibiotic activity and make more informed decisions about the use of antibiotics in practice.
Bayer has also developed an online self-assessment quiz that allows vets and students to check their knowledge. The quiz and the guide are both available at www.veraflox.co.uk
References
The information has been made available amid concerns from behaviourists and animal welfare organisations that there may be a rise in behavioural issues as lifestyle restrictions are lifted.
The Q&A explains what some of the behavioural concerns are and how they can be prevented and managed. Topics include separation-related issues, animals becoming anxious as the world around them becomes busier and noisier, and puppies lacking appropriate skills when greeting animals (including dogs and people) from other households.
The Q&A can be downloaded here.
Dr Hannah Donovan, vet, clinical animal behaviourist and Social Media Officer at the BVBA said: “We hope that this information will help vets to support their clients and their pets when faced with potential challenges as we transition out of lockdown.”
Professor Ian Ramsey, President of the BSAVA added: “This guidance has been developed in collaboration with the BVBA with the intention of supporting vets in practice in an ever-changing environment. It sits alongside other practical BSAVA resources vets can share with pet owners, such as Vaccination Guidance and Neutering Guidance, and follows the BSAVA’s core ethos – ‘By the profession for the profession.”
The BSAVA has also created a collection of resources for veterinary professionals relating to the prevention, management and treatment of behavioural issues in cats of dogs, which is freely available in the BSAVA Library until the end of July.
The collection includes chapters from the BSAVA Manual of Canine and Feline Behavioural Medicine; for those wishing to buy the full manual, there is a £10 discount on both the print and online editions throughout July (using code BEHAV10 on checkout).
Further information for vets can be found in the BSAVA’s COVID-19 resources here.
Shor-Line has announced the launch of YesWeCanSee, a webcam system which allows veterinary surgeons to monitor inpatients from anywhere, over the internet.
The system allows you to watch, listen to and record or photograph the patient remotely. In addition, there is a built-in light which can be used to illuminate or stimulate the patient.
Steffan Veterinary Services, a seven-vet mixed practice based in Lampeter, Ceredigion, recently bought the system and used it to monitor a RTA patient. Jim Hopkins, a director at the practice said: "Boio was unfortunately run over by his owner. He was brought to the practice and hospitalised for monitoring and treatment. Due to his status on arrival he was given pain relief and intravenous fluids. He was kennelled and kept quiet with minimal disturbance. The camera was used to avoid unnecessary contact. The camera could also be turned to check that the IV fluids were running. Once stable and pain relief was working he was radiographed and fully examined. There was a slight increase in respiratory rate but he was otherwise OK. He was kept overnight and monitored. During the evening when checked in person, Boio was settled and not showing any pain, however when remotely monitored he was pacing the kennel and appeared anxious. Further pain relief, Vetergesic, was administered and then Boio settled for the night. Without the camera it is unlikely he would have had further Vetergesic. The following morning Boio was sore but well enough to return home. He has since made a full recovery”.
For more information about YesWeCanSee, visit: www.yeswecansee.com, contact Dan Puddick on 01446 772041 or email ywcs@shor-line.co.uk
Horiba Medical - UK has launched MLT-Diode Laser Systems, specifically designed for veterinary use, as part of its portfolio of animal healthcare products.
According to the company, the MLT-Diode Lasers are highly versatile and can be used in a variety of veterinary applications including surgery, endoscopy, dentistry and irradiation.
The two models, the MLT-Diode Laser Classic and Premium, both feature touch screen controls and are adaptable to each users individual preferences. Designed with small animal practices in mind, the Classic has a performance out-put of 8 watts whilst the more powerful Premium model is for equine medicine with an output of 15 watts. The system is mounted on a mobile cart with a protection case, allowing the whole system to be moved between treatment rooms and enabling near patient application.
Horiba Medical will be exhibiting the MLT-Diode Laser Systems at the London Vet Show at Olympia, 22nd to 23rd October 2010, on Stand M4.
Vetoquinol UK has launched Marbocyl Solo – a one shot treatment for Bovine Respiratory Disease. Marbocyl Solo is a 100mg/ml solution of marbofloxacin given as one injection IM at 8mg/kg. It treats sick animals fast, killing bacteria in one go, therefore minimising lung damage and consequential morbidity. This fast action reduces the risk of the spread of infection. On top of that, Marbocyl Solo has a meat withdrawal of only 3 days (milk 3 days). “Marbocyl is a well proven antibacterial that is extensively used in cattle practice,” explains Alvin Cerely, Marbocyl’s product manager. “Marbocyl Solo is exceptionally well placed for applying ‘concentration killing’ or a‘strike action’ strategy as opposed to a ‘long action’ strategy used by other antibiotics. Marbocyl Solo is available as a separate presentation to Marbocyl 10% to avoid confusion, particularly with farmers, on different dosage regimes and withdrawal periods.”
Marbocyl Solo is available now and details have been mailed to all cattle vets in the UK and Ireland. Please contact your Vetoquinol representative or telephone 0800 169 8197 for more details.
BSAVA Congress, which is open to the whole practice, from reception to the clinical team, will offer free practical drop-in sessions, day-in-the-life dramas, and a bigger wellbeing zone.
There'll be over 120 hours of CPD covering a range of topics such as oncology, veterinary leadership, the RVN’s role, and charity veterinary care.
Paul Higgs, Chair of the Congress Committee, said: “I cannot wait for BSAVA 2023!
"After the successful transformation of BSAVA in our move to Manchester we have been working our socks off to go one better!
"Filled with brilliant speakers, our now trade-mark combination of short, paired lectures with stimulating and inspiring panel discussions, is back in strength.”
Early-bird tickets for BSAVA Congress 2023 are on sale now and BSAVA has brought back one-day only tickets, so if you can’t attend all three days, you have the option to visit on a day that suits you.
https://www.bsavaevents.com/bsavacongress2023/en/page/home
BovIntel is software which, alongside the company's Easi-Scan:Go bovine ultrasound scanner, automatically identifies and measures important features on ultrasound images in real time as a vet carries out a scan.
The software uses colour to highlight and label structures such as follicles and corpus luteums, displaying the measurements of these to the nearest millimetre.
The technology has been designed to make the fertility scanning process easier and more accurate, helping vets give more informed breeding advice.
The developers behind BovIntel say the information that it provides will improve pregnancy rates and therefore overall productivity of dairy herds.
Alan Picken, Imaging Innovation Director said: “Pregnancy rates are notoriously low in the US and across Europe with as few as one in three inseminations producing a pregnancy.
"This is costing the industry time and money.
“Diagnostics on ovarian health is only possible through ultrasound and veterinary assessment, but not all vets are offering this service to their clients.
"BovIntel makes this ultrasound information more accessible to vets, and vastly increases the value and efficacy of the advice they provide to clients.
“Essentially, it enables a vet to quickly and accurately assess the ovarian health of a cow, so they can advise on how to achieve conception at the earliest opportunity.
"Equally, it allows them to quickly establish if a cow is unlikely to get pregnant and prevent a wasted insemination.”
IMV Technologies says new technology also promises to reduce the fertility scanning training time of newly qualified vets, by helping them to quickly find the ovaries during a scan and giving them confidence in interpreting ultrasound images.
Aland added “New vets will be able to practice independently faster and need the support of senior vets for less time, both of which brings huge benefits to their confidence and professional development and to the productivity of the business.”
IMV says the technology will also be useful for universities and research organisations investigating dairy cow reproductive health.
BovIntel is a software addition to IMV’s Go:Scan app.
It can be used via the viewing app, but also with BUG headsets, augmenting in colour for VGA and colour OLED. For users with mono BUG:Go headsets it will appear as grayscale on the headset screen, but in colour on the viewing app.
There's a 30-day free trial of the software for vets using the Go:Scan app, after which there is a choice of a subscription or pay-as-you-scan.
The RCVS Trust is offering vets, veterinary nurses and their friends chance to win a stylish small car - and support this small charity - for a mere £2.00.
On offer in this better-than-the-average raffle is a Fiat 500, the 2008 European Car of the Year winner - and described by Jeremy Clarkson as "practical without being boring".
You can buy tickets online at http://www.everyclick.com/rcvstrust until 21 August, or ask Sarah Briggs at the Trust (020 7202 0743 or s.briggs@rcvstrust.org.uk) for a book to sell to colleagues, friends and family.
Tickets will then be entered into the Small Charity Car Draw, organised by the Foundation for Social Improvement, with the Trust receiving over 95% of the ticket price. The draw will take place on 1 October 2009.
Intervet/Schering-Plough Animal Health has launched its complimentary blood testing service that allows practitioners to investigate one of the main infectious causes of early embryo loss in sheep flocks.
The annual subsidised Barren EweCheck diagnostic scheme is available from 1st December 2010 until 31st March 2011 for breeding ewe flocks. The service establishes whether Toxoplasma gondii is potentially implicated in any empty or aborting ewes.
According to the company, data from the Barren EweCheck and FlockCheck 2010 schemes showed that 86% of flocks had been exposed to the toxoplasma parasite at some point before blood sampling. As a result, practitioners were able to give clients receiving a positive diagnosis timely advice on disease control and the benefits of a Toxovax vaccination regime.
The company anticipates full availability of Toxovax in 2011 and says its Barren EweCheck blood sample submission pads are available directly from the company's Veterinary Support Group by calling 01908 685685.
Hill's is holding the Top Dog Challenge: a race to see which vet school can mobilise the largest number of students to support the school's nomination as 'Top Dog' before May, for a prize of €10,000 to support student activities.
Voting is already open at www.hillstopdog.com. Once the preliminary round votes are counted the top five colleges will be selected to go through to the next round for final judging at the Southern European Veterinary Conference (SEVC) 2011 in Barcelona at the end of September. One nominated student from each of the participating vet schools will get the chance to enjoy an expenses paid trip to SEVC to act as a student ambassador and one lucky winner will collect the prize on behalf of their school.
Every vote makes a difference and students who want to remind their colleagues to vote can send them a SMS text message direct from the site. A really determined, committed and well organised student body can make all the difference and ensure their college has a place on the winner's podium.
Last year's winner the Hebrew University of Jerusalem won with in excess of 95 per cent of their students voting, so winning presents quite a challenge. But this is the first time UK vet schools have taken part and they could upset the apple cart.
Adrian Pratt, Veterinary Affairs Manager is looking forwards to seeing how students at UK vet schools rise to the challenge. He said: "We really have excellent vet schools in this country and it would be great to see the students demonstrating how UK students can perform on the European stage and the passion and loyalty they have for their own school!"
Virbac has announced the launch of what it describes as an affordable ciclosporin for the treatment of canine atopic dermatitis.
Called Cyclavance, the new product will make its debut at the London Vet Show (Nov 20th/21st at London Olympia).
Cyclavance is presented in a liquid formulation for precise dosing, in a container with a new 'AdaptaCap' designed to ensure leak proof dispensing and give the product a 6 month shelf life after being broached. Cyclavance is offered in four size presentations - 5 ml, 15 ml, 30 ml and 50 ml - to give practices maximum flexibility in its use.
Sarah Walker MRCVS, Product Manager, said: "Atopic dogs present at practices across the country on a daily basis. It is a challenging condition which can be hard to treat successfully because owner compliance is so important. By offering Cyclavance at a great price to give greater appeal, allowing a wider scope of use, and with innovative features, such as the unique AdaptaCap, we aim to help practices achieve better outcomes for their patients and increase the number of clients it is available to.
Bayer Animal Health has organised for prominent clinical microbiologist Dr Joseph Blondeau, from Canada's University of Saskatchewana, to tour the UK in May, giving talks to practitioners about effective antibiotic usage to prevent bacterial resistance.
Bayer's Technical Veterinary Adviser, Lucy Smith, will also be giving a talk: Maximise Treatment Success, which comes at the subject from the practical veterinary side.
Bayer Animal Health Marketing Manager, Dr Markus Edingloh said: "We are incredibly fortunate to work with such an eminent expert. Dr Blondeau is a leading authority on a new parameter that supports a dosing concept to minimise selection of bacterial resistance - the Mutant Prevention Concentration. Fortunately, he is also expert at presenting complex matters in an engaging and memorable way."
He added: "Lucy Smith will share her specific experience of Bayer's recently launched Veraflox (pradofloxacin), the first and only next generation veterinary fluoroquinolone, which has a broad spectrum of treatment which attacks Gram +, Gram - and anaerobic bacteria, in a highly efficacious way.
The evening events take place on: May 14th (Glasgow), May 15th (Derby), May 16th (Swindon) & May 17th (Surrey). Full details in the VetSurgeon Diary.
Each roadshow session is equivalent to 1.5 hours of free Continuing Professional Development (CPD).
To register to attend one of the roadshows, please email animal.health@bayer.com
Nick Hicks, HSBC’s Corporate Area Director in Thames Valley, said: "HSBC has enjoyed a highly effective and longstanding business relationship with Medivet, which went from the purchase of a small veterinary practice in Hendon, North London in 1987, to the acquisition of over 140 practices across the UK today. This latest financing package supports the continuing expansion strategy of this successful and acquisitive business."
Dr Arnold Levy (pictured right), Chief Executive Officer at Medivet, said: "This is the second wave of our acquisition strategy which will see us, as a privately owned company, expand our offering of veterinary practices across the country. Following the success of last year’s acquisitions, which were also funded by HSBC, we have continued our expansion across the UK a lot quicker than anticipated. This is significant progress for our business and testament to our strong financial backing."